Company Overview and News
Kolkata: Warren Tea Ltd, one of India’s oldest tea producers with seven prized tea estates in Assam, is looking to expand its hospitality business with substantial capital expenditure over the next three years, at a time of uncertainty, when plantation owners are faced with rising costs and contracting margins.
Kolkata: A suitor for Assam Co. India Ltd—the country’s oldest surviving and perhaps most prized tea company (in terms of assets), now going through insolvency resolution—has successfully petitioned the National Company Law Tribunal (NCLT) to dilute eligibility conditions for bids.
Faced with political pressure from the Assam government, Tata Global Beverages Ltd has for the time being dropped its plan to sell its 41% stake in Amalgamated Plantations Pvt. Ltd, said key officials.
Mumbai: Mint brings to you your daily dose of top deals reported by newsrooms across the country.
Kolkata: India’s oldest surviving and perhaps the most prized tea company (in terms of its assets) is set to go under the hammer. Even before the information memorandum has been circulated, the 179-year old Assam Co. India Ltd has several suitors: MK Shah Exports Ltd, Warren Tea Ltd and the Dhunseri Group to name a few.
Even as the expression of interest for Assam Company India Ltd (ACIL), which is facing the insolvency resolution process under the National Company Law Tribunal (NCLT), is yet to commence, at least two tea companies have expressed an interest in bidding for the firm. Both of these firms -- Dhunseri Tea & Industries Ltd (DTIL) and Warren Tea -- have been on the lookout for acquiring tea gardens in Assam and may place bids if offered the right valuation.
Advani Hotels & Resorts, Archies, Ashapura Intimates Fashion, Auro Laboratories, Bliss GVS Pharma, Cerebra Integrated Technologies, CHD Developers, Cravatex, Graviss Hospitality, KCP, Orbit Exports, Pee Cee Cosma Spoe, Rama Phosphates, Sat Industries, Shreyans Industries, UFO Moviez, Warren Tea and West Leisure Resorts will declare their Q2 and H1 results on Thursday.
Faced with spiraling cost of production and competition from bought leaf factories (BLF), estate holders in north India are exploring the possibility of converting a part of their plantation land for activities other than growing tea to contain falling profitability.
We encourage visitors to register on IIFL. Registering on the site is absolutely Free and offers you the following benefits.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...